ArticleIndian journal of orthopaedics2025
The Mid-Term Results of Bone Marrow Stimulation in the Treatment of Talus Osteochondral Lesions: A 5-Year Follow-Up Study.
Article in Indian journal of orthopaedics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Arthroscopic bone marrow stimulation (BMS) is widely used for treating small osteochondral lesions of the talus (OLT). Although its short-term efficacy is well-established, mid- and long-term outcomes remain ambiguous. This study evaluates the 5-year follow-up results of arthroscopic BMS with a focus on pain and functional recovery. Methods: We conducted a cohort study at a traumatology and orthopedic department on patients with OLT during 5-year follow-up period. Follow-up evaluations included magnetic resonance imaging (MRI) and computed tomography (CT) scans. Pain levels and functional outcomes were assessed using the American Orthopaedic Foot and Ankle Society (AOFAS) score and the Visual Analogue Scale (VAS) at one and five years postoperatively. The study was conducted retrospectively, follow-up time points were determined in accordance with the standard protocol adopted in the clinic. Results: The mean AOFAS score significantly improved from 67.1 ± 9.4 preoperatively to 86.5 ± 12.5 at one year (p < 0.05) and remained consistent at five years (85.7 ± 11.2; p > 0.05). The VAS score showed a marked reduction from 6.4 ± 1.4 preoperatively to 1.6 ± 2.3 at one year (p < 0.05) and 1.9 ± 2.4 at five years (p > 0.05). CT scans confirmed a substantial decrease in lesion size postoperatively, with no significant changes between the one- and five-year evaluations. Conclusion: Arthroscopic BMS demonstrates sustained clinical benefits for OLT, providing significant pain relief and functional improvement over a mid-term period.Level of Evidence:4. Supplementary Information: The online version contains supplementary material available at 10.1007/s43465-025-01527-x.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.